Sleep Apnea – An Inherited Condition Triggered by Lifestyle Factors

Avi Weisfogel has worked as a dentist for over two decades. His experience in dentistry and sleep apnea treatment has the same experience. For more than one decade, he has been involved in the dental practice as a high-end practitioner. As a matter of fact, no one has the better business capability in this field than Avi Weisfogel. When he was joining the New York University Dentistry College, his main passion was to become the best dentist in the world. For this reason, he worked extra hard to realize his dreams in this field. When he graduated, he founded his business in New Jersey. For this reason, business went on as usual. He was confronted with the first case of sleep apnea during the first week of his practice. Because he had limited knowledge concerning this ailment, he decided to develop further study into this field. For this reason, business was going on as usual.

Avi Weisfogel also founded the Dental Sleep Masters Company to enhance his study and research into the various treatment therapies associated with sleep apnea. The company was one of the best marketing instruments of Avi Weisfogel. I led to his recognition by the American Medical Association. His recognition has brought him a lot of success. When doctors and other medical practitioners heard about him, they decided to join the Dental Sleep Masters training program that allows them to acquire knowledge about the applications of various sleep apnea therapies while the cure of sleep apnea is not yet established, treatments will remain a better option in this field. For his reason, better business is a primary concern in this arena.

Avi Weisfogel has dedicated his life to the establishment of sleep apnea therapies. During his later times in practice, he decided to dedicate his life to the development of sleep apnea cure. For this reason, his recognition in the industry is adopted on a massive scale. Sleep apnea is a medical condition that rendered the upper breathing nozzles closed. For this reason, breathing also becomes harder for the patients. In the recent study, sleep apnea causes more than 2,000 deaths each year.

Social Media:

Clay Siegall Won’t Rest Till Cancer Gets A Cure

Clay Siegall is a household name especially for those of us interested in medical journals and especially cancer treatment. Dr Siegall’s passion and pursuit for the treatment of cancer drove him to establish Seattle Genetics in 1998 together with others who share his dream. So far, he has led the company into partnering and working alongside Astellas, Bayers, Pfizer and AbbVie to help treat tumors and other cancer related illnesses.

Dr Siegall has conducted hundreds of clinical experiments and uses innovation to drive his company. So far the company has been able to introduce various treatments that help with cancer healing. The company concentrates on therapies that are based on antibodies, which are purposed to kill cancer cells. Together with his pool of professional scientists and doctors, Dr Siegall has introduced ADRECITRIS, a drug that has been approved by FDA and has received acclamation in the treatment of cancer.

Dr Siegall has an extensive knowledge and experience in medicine and especially in genetics. He has a degree in zoology from University of Maryland and a Ph. D in genetics from George Washington University. With his Ph. D he was able to secure him various positions in different companies. He was a fellow at The National Cancer Institute and also worked at Bristol Myers Squibb Pharmaceutical Research Institute as a senior research investigator. Working at these institutions, he gathered extensive knowledge and skills to conduct research and clinical experiments that helped him start Seattle Genetics.

Dr Siegall is not only an expert in research and oncology but is also an incredible businessman. As the president and the chief executive officer he plays a vital role in the business aspect of the company. He in charge of all that goes on in the company and makes sure that the company stays afloat. He is also responsible for developing strategies that are useful for the company to push forward. Through his leadership, he has been able to obtain 1.2 billion and more as funds for the company.

Dr Siegall is a determined and compassionate man. He is dedicated to his career and looks forward for the day cancer gets a cure.